🚀 VC round data is live in beta, check it out!
Arterra Bioscience Valuation Multiples
Discover revenue and EBITDA valuation multiples for Arterra Bioscience and similar public comparables like Isofol Medical, Sprint Bioscience, Gensight Biologics, Aelis Farma and more.
Arterra Bioscience Overview
About Arterra Bioscience
Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.
Founded
2004
HQ
Employees
34
Website
Sectors
Financials (FY)
EV
$18M
Arterra Bioscience Financials
Arterra Bioscience reported last fiscal year revenue of $5M and EBITDA of $2M.
In the same fiscal year, Arterra Bioscience generated $4M in gross profit, $2M in EBITDA, and $2M in net income.
Arterra Bioscience P&L
In the most recent fiscal year, Arterra Bioscience reported revenue of $5M and EBITDA of $2M.
Arterra Bioscience expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $5M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $4M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 88% | XXX | XXX | XXX |
| EBITDA | — | XXX | $2M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 49% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 35% | XXX | XXX | XXX |
| Net Profit | — | XXX | $2M | XXX | XXX | XXX |
| Net Margin | — | XXX | 32% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Arterra Bioscience Stock Performance
Arterra Bioscience has current market cap of $21M, and enterprise value of $18M.
Market Cap Evolution
Arterra Bioscience's stock price is $3.30.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $18M | $21M | 0.3% | XXX | XXX | XXX | $0.24 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialArterra Bioscience Valuation Multiples
Arterra Bioscience trades at 3.7x EV/Revenue multiple, and 7.6x EV/EBITDA.
Arterra Bioscience Financial Valuation Multiples
As of March 19, 2026, Arterra Bioscience has market cap of $21M and EV of $18M.
Equity research analysts estimate Arterra Bioscience's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Arterra Bioscience has a P/E ratio of 13.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $21M | XXX | $21M | XXX | XXX | XXX |
| EV (current) | $18M | XXX | $18M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 3.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 7.6x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 10.6x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 4.2x | XXX | XXX | XXX |
| P/E | — | XXX | 13.9x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 38.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Arterra Bioscience Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Arterra Bioscience Margins & Growth Rates
Arterra Bioscience's revenue in the last fiscal year grew by 25%.
Arterra Bioscience Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 25% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 49% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 11% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 52% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Arterra Bioscience Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Isofol Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Sprint Bioscience | XXX | XXX | XXX | XXX | XXX | XXX |
| Gensight Biologics | XXX | XXX | XXX | XXX | XXX | XXX |
| Aelis Farma | XXX | XXX | XXX | XXX | XXX | XXX |
| Nanogroup | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Arterra Bioscience M&A Activity
Arterra Bioscience acquired XXX companies to date.
Last acquisition by Arterra Bioscience was on XXXXXXXX, XXXXX. Arterra Bioscience acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Arterra Bioscience
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialArterra Bioscience Investment Activity
Arterra Bioscience invested in XXX companies to date.
Arterra Bioscience made its latest investment on XXXXXXXX, XXXXX. Arterra Bioscience invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Arterra Bioscience
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Arterra Bioscience
| When was Arterra Bioscience founded? | Arterra Bioscience was founded in 2004. |
| Where is Arterra Bioscience headquartered? | Arterra Bioscience is headquartered in Italy. |
| How many employees does Arterra Bioscience have? | As of today, Arterra Bioscience has over 34 employees. |
| Is Arterra Bioscience publicly listed? | Yes, Arterra Bioscience is a public company listed on Borsa Italiana. |
| What is the stock symbol of Arterra Bioscience? | Arterra Bioscience trades under ARBS ticker. |
| When did Arterra Bioscience go public? | Arterra Bioscience went public in 2019. |
| Who are competitors of Arterra Bioscience? | Arterra Bioscience main competitors are Isofol Medical, Sprint Bioscience, Gensight Biologics, Aelis Farma. |
| What is the current market cap of Arterra Bioscience? | Arterra Bioscience's current market cap is $21M. |
| What is the current revenue of Arterra Bioscience? | Arterra Bioscience's last fiscal year revenue is $5M. |
| What is the current EV/Revenue multiple of Arterra Bioscience? | Current revenue multiple of Arterra Bioscience is 3.7x. |
| Is Arterra Bioscience profitable? | No, Arterra Bioscience is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.